BONDANELLI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 6.555
EU - Europa 3.140
AS - Asia 1.174
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.891
Nazione #
US - Stati Uniti d'America 6.522
DE - Germania 1.165
CN - Cina 871
UA - Ucraina 654
IT - Italia 445
TR - Turchia 284
GB - Regno Unito 207
RU - Federazione Russa 189
FI - Finlandia 137
PL - Polonia 116
SE - Svezia 108
FR - Francia 54
BE - Belgio 37
MX - Messico 16
CA - Canada 13
BR - Brasile 8
IN - India 7
IE - Irlanda 6
CZ - Repubblica Ceca 5
EC - Ecuador 4
IR - Iran 4
RO - Romania 4
NL - Olanda 3
CL - Cile 2
EU - Europa 2
GR - Grecia 2
JP - Giappone 2
PA - Panama 2
PE - Perù 2
VE - Venezuela 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ES - Italia 1
HN - Honduras 1
KZ - Kazakistan 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PT - Portogallo 1
Totale 10.891
Città #
Woodbridge 905
Chandler 722
Jacksonville 675
Fairfield 604
Houston 394
Ashburn 388
Ann Arbor 342
Wilmington 276
Seattle 211
Izmir 206
Addison 202
Nanjing 202
Beijing 192
Cambridge 183
Princeton 154
Warsaw 116
New York 93
San Diego 93
Milan 84
Shenyang 70
Boardman 65
Shanghai 59
Ferrara 58
Hebei 56
Dearborn 50
Nanchang 46
Bremen 39
Brussels 37
Changsha 33
Tianjin 32
Jiaxing 30
Falls Church 25
Kunming 24
Redwood City 24
Jinan 23
Mountain View 23
Norwalk 21
Washington 20
Zhengzhou 17
London 16
Helsinki 15
Ningbo 15
San Mateo 14
Guangzhou 13
Auburn Hills 12
Hefei 11
Orange 11
Bologna 10
Leawood 9
Rome 9
Taizhou 9
Des Moines 7
Los Angeles 7
Monmouth Junction 7
Philadelphia 7
Tappahannock 7
Augusta 6
Castelnuovo Rangone 6
Changchun 6
Hangzhou 6
Indiana 6
Redmond 6
Chicago 5
Dallas 5
Lanzhou 5
Toronto 5
Verona 5
Mexico 4
Pisa 4
Quito 4
Salerno 4
Treviso 4
Andover 3
Ardabil 3
Brno 3
Caiazzo 3
Cordovado 3
Haikou 3
Jinhua 3
Montréal 3
Mumbai 3
Munich 3
Napoli 3
Rimini 3
Terni 3
Walnut 3
Acton 2
Amsterdam 2
Bollate 2
Brembate 2
Cairate 2
Catania 2
Chiswick 2
Cuauhtémoc 2
Dong Ket 2
Fuzhou 2
Hanover 2
Hounslow 2
Langhirano 2
Lima 2
Totale 7.124
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 235
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 148
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 145
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 141
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 136
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 132
null 130
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 129
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 124
Role of the serotonergic system in the genesis of vasovagal syncope. 120
Pituitary side effects of old and new drugs. 120
Cerebral aneurysm and acromegaly: a case report 119
null 118
null 114
In vitro testing of new somatostatin analogs on pituitary tumor cells 114
null 113
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 112
null 111
L’iperplasia surrenale congenita e la pubertà precoce 111
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 110
Acromegaly is associated with increased cancer risk: a survey in Italy 107
null 106
null 106
null 104
Growth hormone excess promotes breast cancer chemoresistance 103
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 103
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 102
null 101
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 99
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 99
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 98
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 98
null 98
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 95
Le alterazioni pressorie nell'acromegalia: fattori umorali 94
Predictors of morbidity and mortality in acromegaly: An Italian survey 93
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 92
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 91
null 91
Diurnal rhythm of plasma catecholamines in acromegaly 90
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 88
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 88
null 88
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 87
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 87
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 85
Prevalence of hypopituitarismin patients with cerebrovascular diseases 84
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 84
Glucose metabolism alterations in acromegaly 83
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 83
Delta opioid receptor involvement in endocrine pathophysiology 82
Antiproliferative effects of somatostatin analogs in pituitary adenomas 82
Occurrence of pituitary dysfunction following traumatic brain injury 81
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 81
Systemic illness 80
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 80
Sindrome di McCune-Albright 80
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 80
Cerebrovascular disease and GH-IGF-i axis function 80
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 79
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 79
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 79
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 79
Functional hypothalamic and drug-induced amenorrhea: an overview 79
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 78
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 78
Sistema Simpatoadrenomidollare nei pazienti acromegalici 77
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 76
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 75
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 75
Human galanin reduces plasma norepinephrine levels in man 74
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 71
IPOPITUITARISMO E TRAUMA CRANICO. 71
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 70
Vecchi e nuovi analoghi della somatostatina e loro meccanismo d'azione 70
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 70
Pathogenesis and prevalence of hypertension in acromegaly 70
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy. 70
GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. 69
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 69
Review of Cortina criteria for the diagnosis of acromegaly 68
Fisiopatologia del sistema vasopressina 68
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 68
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 68
ASSE GH-IGF-I NELL'INVECCHIAMENTO 68
INVECCHIAMENTO E GH 68
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 68
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 67
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 67
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 67
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 66
Sindrome di Von Hippel-Lindau 65
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 65
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 65
Replacement therapy and quality of life improvement in adult GHD patients 65
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 65
Targeting PKC in human pancreatic neuroendocrine tumor cells 64
Efficay and safety of teriparatide treatment 64
A new VHL polymorphism in a big family from Ferrara 63
Fisiopatologia dei recettori della somatostatina 62
Totale 9.014
Categoria #
all - tutte 37.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.921
Totale 42.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.011 0 0 0 0 0 0 0 0 134 202 177 498
2019/20202.038 394 54 66 277 115 249 129 210 117 261 135 31
2020/20211.368 147 104 58 169 63 147 37 162 31 185 198 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.544 155 136 52 203 207 230 78 115 218 21 69 60
2023/2024617 71 97 55 30 59 176 25 79 25 0 0 0
Totale 11.047